SOPHiA GENETICS (SOPH) Gross Profit (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Gross Profit data on file, last reported at $14.7 million in Q4 2025.

• For the quarter ending Q4 2025, Gross Profit rose 21.4% year-over-year to $14.7 million; the trailing twelve-month figure through Dec 2025 stood at $52.1 million (up 18.53% YoY), and the FY2025 full-year result was $52.1 million, up 18.53% from the prior year.
• Gross Profit climbed to $14.7 million in Q4 2025, from $12.9 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $14.7 million in Q4 2025 to a low of $5.6 million in Q1 2021.
• A 5-year average of $9.8 million and a median of $10.2 million in 2023 frame the typical range for Gross Profit.
• Peak annual rise in Gross Profit reached 153263.02% in 2021, while the deepest fall reached 99.84% in 2021.
• Tracing SOPH's Gross Profit over 5 years: stood at $6.8 million in 2021, then soared by 41.01% to $9.6 million in 2022, then grew by 23.54% to $11.9 million in 2023, then grew by 1.71% to $12.1 million in 2024, then increased by 21.4% to $14.7 million in 2025.
• Business Quant data shows SOPH's Gross Profit at $14.7 million in Q4 2025, $12.9 million in Q3 2025, and $12.3 million in Q2 2025.